Aims and Scope | Advanced Drug Sciences

About Journal

Advanced Drug Sciences (ADS) is an international, peer-reviewed Gold Open Access journal published by Universitas Muhammadiyah Surakarta (UMS), Indonesia. The journal is dedicated to advancing the science of drug discovery, development, and therapeutic application by publishing high-quality, original, and interdisciplinary research.

ADS provides a multidisciplinary platform that integrates pharmaceutical, biomedical, and clinical sciences, with a strong emphasis on mechanistic understanding, technological innovation, and translational relevance.

The journal aims to bridge the continuum from molecular design and formulation to clinical outcomes and population-level health impact.

The journal operates under a Gold Open Access model, ensuring that all accepted articles are immediately and permanently accessible without subscription barriers. Articles are published under a continuous publication model to enable rapid dissemination of scientific findings.

ADS welcomes contributions that advance both fundamental knowledge and practical applications in drug sciences, including, but not limited to, drug discovery and medicinal chemistry, pharmaceutics and advanced drug delivery, pharmacology and pharmacokinetics, biopharmaceuticals and biotechnology-derived therapeutics, and clinical and translational research.

Through rigorous peer review and adherence to internationally recognized ethical standards, ADS is committed to publishing scientifically robust research that contributes to innovation in drug development and the improvement of global healthcare outcomes.

Advanced Drug Sciences publishes high-quality, peer-reviewed research and authoritative reviews spanning the full continuum of drug discovery, development, and clinical application. The journal emphasizes mechanistic understanding, technological innovation, and translational impact across pharmaceutical and biomedical sciences.

ADS particularly aims to integrate advances from molecular design to real-world therapeutic outcomes, supporting a multidisciplinary and systems-level approach to drug science.

Core Scientific Domains

Drug Discovery and Design

Medicinal chemistry, structure–activity relationships, and molecular optimization
Computational approaches, including molecular docking, in silico modeling, cheminformatics, and AI-driven drug discovery
Synthetic and natural product-based lead identification

Drug Delivery and Pharmaceutical Sciences

Advanced formulation and delivery systems, including nanocarriers and targeted delivery
Biopharmaceutics, stability, and predictive analytical characterization
Mechanistic and model-based formulation development

Pharmacology and Safety Sciences

Molecular and systems pharmacology, receptor and signaling mechanisms
Pharmacodynamics and translational pharmacology
Preclinical and experimental toxicology

Translational and Clinical Sciences

Clinical trials, pharmacotherapy optimization, and precision medicine
Real-world evidence and patient-centered outcomes

Regulatory Science and Drug Safety

Pharmacovigilance, regulatory evaluation, and lifecycle management
Risk–benefit assessment and post-marketing surveillance

Health Systems, Policy, and Outcomes Research

Pharmacoeconomics, access to medicines, and healthcare decision-making
Pharmacoepidemiology, rational drug use, and adherence
Public health interventions related to medicine use

Frontier and Interdisciplinary Areas

Pharmacognosy and bioactive natural products, including sustainable and ethnopharmacological approaches
Biopharmaceuticals, vaccines, gene and cell therapies, and biomaterials
Integration of pharmaceutical sciences with data science, artificial intelligence, systems biology, and biomedical engineering